Yasuhiro Nishiyama, Kazumi Kimura, Toshiaki Otsuka, Kazunori Toyoda, Shinichiro Uchiyama, Haruhiko Hoshino, Nobuyuki Sakai, Yasushi Okada, Hideki Origasa, Hiroaki Naritomi, et al. Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial. Stroke. 2023. 54. 3. 697-705
Shinichiro Uchiyama, Kazunori Toyoda, Satomi Okamura, Katsuhiro Omae, Haruhiko Hoshino, Kazumi Kimura, Kazuo Kitagawa, Kazuo Minematsu, Takenori Yamaguchi. Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial. International journal of stroke : official journal of the International Stroke Society. 2022. 17474930221112343-17474930221112343
Keisuke Tokunaga, Masahiro Yasaka, Kazunori Toyoda, Etsuro Mori, Teruyuki Hirano, Toshimitsu Hamasaki, Hiroshi Yamagami, Takehiko Nagao, Shinichi Yoshimura, Shinichiro Uchiyama, et al. Bridging Therapy With Heparin Before Starting Rivaroxaban in Ischemic Stroke or Transient Ischemic Attack With Non-Valvular Atrial Fibrillation. Circulation journal : official journal of the Japanese Circulation Society. 2022. 86. 6. 958-963
Kazunori Toyoda, Katsuhiro Omae, Haruhiko Hoshino, Shinichiro Uchiyama, Kazumi Kimura, Kaori Miwa, Kazuo Minematsu, Keiji Yamaguchi, Yoshitaka Suda, Shuta Toru, et al. Association of Timing for Starting Dual Antiplatelet Treatment With Cilostazol and Recurrent Stroke: A CSPS.com Trial Post Hoc Analysis. Neurology. 2022. 98. 10. e983-e992
